Skip to main content
. 2023 Jan 27;11(1):37–43. doi: 10.1007/s40136-023-00440-x

Table 1.

Pros and cons on treatment modalities for pediatric allergic rhinitis (AR)

Medication Pros Cons
Oral H1 antihistamines Non-sedating antihistamine as the first-line treatment and well tolerable Mild fatigue, headache, nausea, dry mouth, poor drug adherence
Intranasal antihistamines First or second-line treatment, effective for ocular symptoms Concerns for patient tolerance, especially with regard to taste
Intranasal corticosteroids

First or second-line treatment

All nasal symptoms relief as well as ocular symptoms

Nasal irritation, epistaxis, slow onset, some negative effects on short-term growth in children, but it is unclear for long term
Oral decongestant For short-term relief of nasal obstruction Insomnia, loss of appetite, irritability, palpitations, and increased blood pressure. Risk of toxicity in young children
Topical decongestant For short-term nasal decongestion Chronic use may carry the risk of rhinitis medicamentosa. Rebound congestion
Leukotriene receptor antagonist For AR combined asthma symptoms relief

Little effect as monotherapy for AR

Cost

Cromones As alternative for patient cannot tolerate intranasal corticosteroid Nasal irritation, slow onset, frequent dosing needed
Ipratropium nasal spray Adjunct to intranasal corticosteroid for the uncontrolled rhinorrhea Nasal irritation, headache, pharyngitis, epistaxis, nasal dryness, over-dosing
Nasal saline douching

Adjunct to pharmacotherapy

Effective in discharge removal

Practice and education needed, intranasal irritation, headaches, and ear pain
Combination: intranasal antihistamine and corticosteroid Rapid onset, effective when monotherapy fail to control symptoms. Used as second-line therapy

Patient intolerance, especially due to taste

Cost